• Aquestive Therapeutics Chief Commercial Officer Sherry Korczynski exercised stock options for 8,750 shares at $2.65 on Sept. 9, 2026.
• She sold 8,750 shares at $5.22 on the same day.
• Directly held common stock totaled 235,689 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-011596), on September 11, 2026, and is solely responsible for the information contained therein.